Francisco Matellano-Vivancos
La Paz, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Validation of the OPTIMIPARK Questionnaire: A Tool to Optimize Treatment in Parkinson's Disease.
Journal: Movement disorders clinical practice
Published: May 17, 2022
Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders
Journal: Revista de neurologia
Published: November 18, 2020
Hemifacial spasm through the last three decades: From etiology to efficacy and safety of long-term botulinum toxin treatment.
Journal: Clinical neurology and neurosurgery
Published: June 03, 2020
Efficacy and Safety of Long-Term Therapy with Type A Botulinum Toxin in Patients with Blepharospasm.
Efficacy and Safety of Long-Term Therapy with Type A Botulinum Toxin in Patients with Blepharospasm.
Journal: Neuro-ophthalmology (Aeolus Press)
Published: September 25, 2018
Chorea following extracorporeal circulation in adults: A case report and brief literature review.
Journal: Neurologia
Published: May 07, 2018
Spanish expert consensus on the use of safinamide in Parkinson's disease.
Journal: Neurologia
Published: December 21, 2017
Spanish expert consensus on the use of safinamide in Parkinson's disease.
Journal: Neurologia
Published: December 21, 2017
Pharmacoeconomic study of the treatment of advanced Parkinson's disease
Journal: Revista de neurologia
Published: November 30, 2016
A 17-year experience of abobotulinumtoxina in cervical dystonia.
Journal: The International journal of neuroscience
Published: February 15, 2012
Assessment of Parkinson disease: what do we need to show neuroprotection?
Journal: The neurologist
Published: November 03, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026